Atlas Trials

Etrasimod for Immune Checkpoint Inhibitor Diarrhea and Colitis

Clinical trial NCT06521762 · WITHDRAWN

Trial details

NCT number
NCT06521762
Sponsor
Yale University
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Immune Checkpoint Inhibitor-Related Diarrhea and Colitis
Start date
2026-01-01
Primary completion
2029-01-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.